MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in CADL — Candel Therapeutics, Inc.

CIK 1705339 CAUSEWAY BAY, K3

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$367,915

+$264,658 QoQ

Shares Held

35,720

+69.5% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 138 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $436,102,859 across 286 Biotechnology names. CADL ranks #151 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	150,692	$74,853,236
2	REGN	Regeneron Pharmaceuticals, Inc.	59,595	$37,159,864
3	ALNY	Alnylam Pharmaceuticals, Inc.	63,265	$19,044,662
4	RPRX	Royalty Pharma plc	259,390	$14,543,997
5	INCY	Incyte Corp	83,084	$9,418,401
6	PRAX	Praxis Precision Medicines, Inc.	27,185	$9,101,265
7	MRNA	Moderna, Inc.	106,564	$7,462,676
8	CRSP	CRISPR Therapeutics AG	122,658	$6,689,766

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$367,915	35,720	+69.5%	Shares	Defined	2026-08-14
2026-03-31	$103,257	21,073	+5.4%	Shares	Defined	2026-05-15
2025-12-31	$113,000	20,000	+2.8%	Shares	Defined	2026-02-17
2025-09-30	$99,256	19,462	-9.6%	Shares	Defined	2025-11-14
2025-06-30	$108,891	21,520	+28.5%	Shares	Defined	2025-08-14
2025-03-31	$94,626	16,748	+37.7%	Shares	Defined	2025-05-15
2024-12-31	$105,592	12,165	+12.4%	Shares	Defined	2025-02-14
2024-09-30	$75,017	10,825	—	Shares	Defined	2024-11-14
No filing history on record for this holder in this stock.